Shanghai Kaibao Pharmaceutical (300039) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.042x

Based on the latest financial reports, Shanghai Kaibao Pharmaceutical (300039) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥190.98 Million ≈ $27.95 Million USD) by net assets (CN¥4.55 Billion ≈ $665.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shanghai Kaibao Pharmaceutical (300039) total market value for the company's overall valuation and market capitalisation.

Shanghai Kaibao Pharmaceutical - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Shanghai Kaibao Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai Kaibao Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Kaibao Pharmaceutical ranked by their cash flow conversion efficiency. Explore earnings quality score of Shanghai Kaibao Pharmaceutical to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
DBV Technologies
NASDAQ:DBVT
-0.518x
Sheela Foam Limited
NSE:SFL
0.036x
Zhejiang Zanyu Technology Co Ltd
SHE:002637
0.028x
Worldline SA
PA:WLN
0.032x
Karnov Group AB
ST:KAR
0.108x
Groupon Inc
NASDAQ:GRPN
-0.113x
Viridien
PA:VIRI
0.097x
Kunming Chuan Jin Nuo Chemical Co Ltd
SHE:300505
0.031x

Annual Cash Flow Conversion Efficiency for Shanghai Kaibao Pharmaceutical (2006–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Kaibao Pharmaceutical from 2006 to 2025. View current stock price of Shanghai Kaibao Pharmaceutical for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥4.42 Billion
≈ $646.60 Million
CN¥230.74 Million
≈ $33.76 Million
0.052x -23.19%
2024-12-31 CN¥4.10 Billion
≈ $600.40 Million
CN¥278.95 Million
≈ $40.82 Million
0.068x -28.35%
2023-12-31 CN¥4.03 Billion
≈ $590.13 Million
CN¥382.66 Million
≈ $56.00 Million
0.095x -5.19%
2022-12-31 CN¥3.76 Billion
≈ $550.36 Million
CN¥376.42 Million
≈ $55.08 Million
0.100x +141.71%
2021-12-31 CN¥3.04 Billion
≈ $445.57 Million
CN¥126.08 Million
≈ $18.45 Million
0.041x -57.41%
2020-12-31 CN¥2.58 Billion
≈ $377.29 Million
CN¥250.65 Million
≈ $36.68 Million
0.097x -25.23%
2019-12-31 CN¥2.57 Billion
≈ $376.00 Million
CN¥334.09 Million
≈ $48.89 Million
0.130x +23.16%
2018-12-31 CN¥2.49 Billion
≈ $363.65 Million
CN¥262.36 Million
≈ $38.39 Million
0.106x +1.62%
2017-12-31 CN¥2.37 Billion
≈ $346.14 Million
CN¥245.76 Million
≈ $35.96 Million
0.104x -27.40%
2016-12-31 CN¥2.20 Billion
≈ $321.97 Million
CN¥314.88 Million
≈ $46.08 Million
0.143x -12.25%
2015-12-31 CN¥2.01 Billion
≈ $293.47 Million
CN¥327.08 Million
≈ $47.86 Million
0.163x +8.85%
2014-12-31 CN¥1.88 Billion
≈ $275.78 Million
CN¥282.38 Million
≈ $41.32 Million
0.150x -10.95%
2013-12-31 CN¥1.61 Billion
≈ $235.02 Million
CN¥270.23 Million
≈ $39.54 Million
0.168x -1.89%
2012-12-31 CN¥1.42 Billion
≈ $207.61 Million
CN¥243.32 Million
≈ $35.61 Million
0.171x +132.79%
2011-12-31 CN¥1.33 Billion
≈ $195.27 Million
CN¥98.31 Million
≈ $14.39 Million
0.074x +360.54%
2010-12-31 CN¥1.24 Billion
≈ $181.01 Million
CN¥19.79 Million
≈ $2.90 Million
0.016x -65.23%
2009-12-31 CN¥1.15 Billion
≈ $167.72 Million
CN¥52.74 Million
≈ $7.72 Million
0.046x -68.76%
2008-12-31 CN¥126.92 Million
≈ $18.57 Million
CN¥18.70 Million
≈ $2.74 Million
0.147x -51.29%
2007-12-31 CN¥76.96 Million
≈ $11.26 Million
CN¥23.27 Million
≈ $3.41 Million
0.302x -42.84%
2006-12-31 CN¥37.24 Million
≈ $5.45 Million
CN¥19.70 Million
≈ $2.88 Million
0.529x --

About Shanghai Kaibao Pharmaceutical

SHE:300039 China Drug Manufacturers - Specialty & Generic
Market Cap
$776.03 Million
CN¥5.30 Billion CNY
Market Cap Rank
#10124 Global
#2688 in China
Share Price
CN¥5.07
Change (1 day)
+0.60%
52-Week Range
CN¥4.18 - CN¥6.66
All Time High
CN¥12.44
About

Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern traditional Chinese medicines primarily in China. The company offers heat-clearing and detoxifying products, such as Tanreqing Injection for wind-heat in the lungs with phlegm-heat obstructing the lungs, early-stage pneumonia, acute bronchitis, acute exacerbations of chronic bronchitis, and… Read more